Thoracic SMARCA4-deficient undifferentiated tumors are rare, with poor
prognosis. A 73-year-old man presented to our hospital with dyspnea.
Computed tomography-guided biopsy revealed a SMARCA4-deficient
undifferentiated tumor. The patient was treated with combination
ipilimumab-nivolumab. The tumor reduced in size after two courses.